Invention Grant
- Patent Title: CXCR2 antibodies and uses thereof
-
Application No.: US15907208Application Date: 2018-02-27
-
Publication No.: US11053319B2Publication Date: 2021-07-06
- Inventor: Charles Reay Mackay , Remy Michel Robert
- Applicant: Monash University
- Applicant Address: AU Clayton
- Assignee: Monash University
- Current Assignee: Monash University
- Current Assignee Address: AU Clayton
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Priority: AU2017900656 20170227
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P29/00 ; A61P35/00
Abstract:
The invention relates to CXCR2, to antibodies and related fragments thereof for binding to CXCR2, to production of said antibodies and fragments and to use of said antibodies and fragments for detection and therapy of various conditions.
Public/Granted literature
- US20190016809A1 CXCR2 ANTIBODIES AND USES THEREOF Public/Granted day:2019-01-17
Information query
